Sanofi plans to spend about $1.05 billion building a new insulin manufacturing base in China, the French company’s largest ...

Sanofi (SNY) intends to spend about $1.05B building a new insulin manufacturing base in China, Kimberley Kao of The Wall Street Journal ...

French drugmaker Sanofi plans to invest 1 billion euros ($1.05 billion) to build a new insulin production base in Beijing, a ...

Shortly after a similarly sized venture from Pfizer, French pharma juggernaut Sanofi has unveiled a major manufacturing ...

French pharma giant Sanofi will invest some 1 billion euros ($1.05 billion) to establish a new insulin production base in ...

Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...

Sanofi is one of the world's top producers of insulin, and the China market for treatment of the illness is huge: Some 140 ...

Sanofi has made its single largest investment in China to date by pouring roughly €1 billion ($1.05 billion) into a new ...

The China-based subsidiary of French pharma major Sanofi revealed it has signed a memorandum of cooperation with Beijing ...

The French pharma firm is seeking to increase insulin production in Beijing as trade tensions between the EU and China simmer ...

French drug major Sanofi plans to invest around 1 billion euros or about $1.05 billion to build a new insulin manufacturing base in ...

French pharma giant Sanofi will invest some 1 billion euros (about 1.05 billion U.S. dollars) to establish a new insulin ...